Using Amazon Web Services (AWS) AppSync service and the AWS Cloud platform, bio-T enables medical devices to fulfill their intended use, be it with or without connectivity to the cloud, while losing no patient or activity data.
Such is the case of Nerivio Migra developed by Theranica.
The Theranica Nerivio Migra is an FDA-approved drug-free therapeutic wearable for the treatment of acute migraine. The connection with the bio-T remote care platform and deployment of the solution on AWS enables a novel way of remotely monitoring migraine patients. Such monitoring implies a promise for personalized medicine where physicians will learn about the Migraine patterns of their patients, to provide better treatment. In the near future, given time for data acquisition, big data analysis of patients worldwide may find the root causes of Migraine – a phenomenon with no clear explanation.
Theranica addressed its challenges by developing a device and mobile application and connecting it to the bio-T remote care platform, combined with the Amazon Web Services (AWS) Cloud. The solution enables the user suffering migraine pain to use the device and app both in online and offline modes, and the bio-T integration with AWS is responsible for data sync letting the user focus on treatment.
bio T™ is providing cloud software for regulated medical device companies enabling them to upgrade any standalone device to a remote care solution in a snap.
With features like adherence prediction, treatment efficacy, and reimbursement management the patent-pending bio-T Engine is a one stop shop for vendors, supporting all the dataway: from device connectivity, security and privacy, to patient interaction and behavior analysis.
Moreover, bio-T™ enables the vendors to retain ownership over the data and to have complete implementation flexibility via code-level customization.
By choosing bio-T vendors enjoy short time to market, assurance of cyber & regulation risks, and more patient outcome features than what they would’ve done in-house.